MRI / Gadolinium Practice Center: MRI Gadolinium Contrast Agent - ALERT Gadolinium Attorneys MRI Gadolinium Lawsuits Gadolinium Causing Medical Condition Nephrogenic Systemic Fibrosis What Is Nephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis? Gadolinium Lawyer We will work under a Contingency Fee Contract

Gadolinium is a basic element that for reasons that are being investigated at this time was injected into individuals veins, prior to undergoing a MRI with Contrast Exam.  Gadolinium was used as a component in contrast dyes for magnetic resonance imaging testing or MRI with Contrast or magnetic resonance angiography (MRA). Unfortunately, a growing number of individuals have been diagnosed with a medical condition known as Nephrogenic Systemic Fibrosis.  It has now been determined that when the compound Gadolinium is injected as a contrast agents it can cause Nephrogenic Systemic Fibrosis or Nephrogenic Fibrosing Dermopathy (NSF/NFD).  The individuals who have suffered or incurred the condition known as NSF were individuals who were having issues with their kidneys or are patients with kidney disease.

The link between Gadolinium, the contrast agent used in MRI and MRA scans and NSF and NFD is now clear. The FDA has issued warnings about the link between Gadolinium and NSF and NFD in kidney patients. Patients who have developed NSF or NFD after getting MRI or MRA scans should contact our Law Firm.  Our Gadolinium Attorneys will take the time to discuss  the condition, discuss your options and provide legal advice and whether compensation for the damages can or should be sought for the development of the medical condition NSF and NFD.

If you have a preexisting kidney disorder or disease and undergone an MRI or MRA with the Contrast Agent - Gadolinium, be alert for signs of the condition known as NSF and NFD. Symptoms can include thickening of the skin, joint stiffness, muscle weakness, dark or reddish skin patches, yellow spots on the whites of the eyes, burning, itching, swelling, and pain in the hip or rib areas. If you develop any of these symptoms after getting an MRI or MRA call our Law Firm. Even if you decide not to launch a Gadolinium lawsuit yourself, discussing all your options and can help you understand your choices.

If you have an existing kidney condition and are scheduled for an MRI or MRA, ask your doctor to not use Gadolinium-containing contrast agents as part of the medial imaging scan. Confirm with the technician administering the scan that no Gadolinium-containing contrast agents are used. You can often avoid NSF and NFD by using different imaging technology or different contrasting agents.

Call our Law Firm, day or night at 1-800-862-1260.






























TRADEMARK NOTICE: Magnevist, Omniscan, OptiMARK, ProHance and Multihance are trademarks of Bayer Schering Pharma, GE Healthcare, Chalfont St. Giles and Bracco Diagnostics Inc. accordingly.

The Carabin & Shaw Law Firm, its' lawyers and this website is in no way affiliated with Bayer Schering Pharma, GE Healthcare, Chalfont St. Giles and Bracco Diagnostics Inc. The use of this mark is solely for informational and product identification purposes.